In Brief: FDA reform conference
This article was originally published in The Rose Sheet
Executive Summary
FDA reform conference: Vote on FDA reform legislation (S 830/HR 1411) report was slated to take place as of Nov. 9. The White House has said it is considering a veto of the conference report because of disagreements over a number of provisions in the legislation. The conference got under way Nov. 5, following several weeks of preconference staff meetings. House conferees include Reps. Tom Bliley (R-Va.), Michael Bilirakis (R-Fla.), Jim Greenwood (R-Penn.), Joe Barton (R-Tex.), Richard Burr (R-N.C.), Ed Whitfield (R-Ky.), John Dingell (D-Mich.), Henry Waxman (D-Calif.), Sherrod Brown (D-Ohio) and Ron Klink (D-Penn.). Senate conferees include James Jeffords (R-Vt.), Dan Coats (R-Ind.), Judd Gregg (R-N.H.), Bill Frist (R-Tenn.), Mike Dewine (R-Ohio), Edward Kennedy (D-Mass.), Christopher Dodd (D-Conn.), Tom Harkin (D-Iowa) and Barbara Mikulski (D-Md.)...